[{"address1": "121 Richmond Street West", "address2": "Penthouse Suite, 1300", "city": "Toronto", "state": "ON", "zip": "M5H2K1", "country": "Canada", "phone": "416 346 7764", "website": "https://www.psyencebiomed.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company's lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder PTSD, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company has a strategic collaboration with PsyLabs to produce Ibogaine. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.", "fullTimeEmployees": 12, "companyOfficers": [{"maxAge": 1, "name": "Mr. Jody  Aufrichtig", "age": 50, "title": "Co-Founder, Executive Chairman & Strategic Business Development Officer", "yearBorn": 1974, "fiscalYear": 2025, "totalPay": 216667, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Neil  Maresky M.D.", "age": 60, "title": "CEO & Director", "yearBorn": 1964, "fiscalYear": 2025, "totalPay": 390000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Warwick Ron Corden-Lloyd", "age": 44, "title": "Chief Financial Officer", "yearBorn": 1980, "fiscalYear": 2025, "totalPay": 195000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Taryn  Vos", "title": "General Counsel", "fiscalYear": 2025, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1767139200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 3.07, "open": 3.06, "dayLow": 2.9, "dayHigh": 3.189, "regularMarketPreviousClose": 3.07, "regularMarketOpen": 3.06, "regularMarketDayLow": 2.9, "regularMarketDayHigh": 3.189, "payoutRatio": 0.0, "beta": 0.179, "trailingPE": 0.07447318, "volume": 100820, "regularMarketVolume": 100820, "averageVolume": 2080369, "averageVolume10days": 2839320, "averageDailyVolume10Day": 2839320, "bid": 3.05, "ask": 3.15, "bidSize": 2, "askSize": 2, "marketCap": 2218151, "fiftyTwoWeekLow": 2.36, "fiftyTwoWeekHigh": 82.8, "allTimeHigh": 8730.0, "allTimeLow": 2.36, "fiftyDayAverage": 4.24874, "twoHundredDayAverage": 7.195755, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -5913516, "profitMargins": 0.0, "floatShares": 70361, "sharesOutstanding": 234280, "sharesShort": 38264, "sharesShortPriorMonth": 80520, "sharesShortPreviousMonthDate": 1755216000, "dateShortInterest": 1757894400, "sharesPercentSharesOut": 0.1633, "heldPercentInsiders": 0.00483, "heldPercentInstitutions": 0.44686002, "shortRatio": 0.31, "shortPercentOfFloat": 0.1633, "impliedSharesOutstanding": 713232, "bookValue": 11.834, "priceToBook": 0.2628021, "lastFiscalYearEnd": 1743379200, "nextFiscalYearEnd": 1774915200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": 1011790, "trailingEps": 41.76, "lastSplitFactor": "125:1000", "lastSplitDate": 1746403200, "enterpriseToEbitda": 1.616, "52WeekChange": -0.94816667, "SandP52WeekChange": 0.1529237, "quoteType": "EQUITY", "currentPrice": 3.11, "recommendationKey": "none", "totalCash": 6135166, "totalCashPerShare": 86.083, "ebitda": -3658754, "totalDebt": 0, "quickRatio": 10.553, "currentRatio": 11.037, "returnOnAssets": -0.54196, "freeCashflow": -3394860, "operatingCashflow": -3734238, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "PBM", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1758930577, "regularMarketTime": 1758916800, "exchange": "NCM", "messageBoardId": "finmb_698500412", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Psyence Biomedical Ltd.", "longName": "Psyence Biomedical Ltd.", "regularMarketChangePercent": 1.30293, "regularMarketPrice": 3.11, "fiftyDayAverageChange": -1.1387403, "fiftyDayAverageChangePercent": -0.26801834, "twoHundredDayAverageChange": -4.0857553, "twoHundredDayAverageChangePercent": -0.56780076, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-01-26", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1639146600000, "postMarketChangePercent": -3.21543, "postMarketPrice": 3.01, "postMarketChange": -0.0999999, "regularMarketChange": 0.04, "regularMarketDayRange": "2.9 - 3.189", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 2080369, "fiftyTwoWeekLowChange": 0.75, "fiftyTwoWeekLowChangePercent": 0.31779662, "fiftyTwoWeekRange": "2.36 - 82.8", "fiftyTwoWeekHighChange": -79.69, "fiftyTwoWeekHighChangePercent": -0.9624396, "fiftyTwoWeekChangePercent": -94.816666, "epsTrailingTwelveMonths": 41.76, "displayName": "Psyence Biomedical", "trailingPegRatio": null, "__fetch_time": "2025-09-27"}]